We believe that the association of greater tumor infiltration of CD14+ cells and greater numbers of CD14+ HLA-DRneg cells with advanced disease strongly suggests that these cells may be part of the pathogenesis of these tumors and should be further investigated as high priority targets for new therapies. The gene discussed is CD14; the disease is neoplasm.